Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 9/20 | 1.00 |
| ▸ | CA12 | O43570 | 7/20 | 1.00 |
| ▸ | CA1 | P00915 | 7/20 | 1.00 |
| ▸ | CA7 | P43166 | 7/20 | 1.00 |
| ▸ | CA13 | Q8N1Q1 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 6/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | HPGD | P15428 | 5/20 | 1.00 |
| ▸ | CASP1 | P29466 | 3/20 | 1.00 |
| ▸ | CASP7 | P55210 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fraxetin SCHEMBL30010613 | 1.00 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| SCHEMBL14296936 | 0.89 | CA9 (0.79) | CA9CA12CA1CA7CA13 | |
| SCHEMBL3190311 | 0.87 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| SCHEMBL30098746 | 0.87 | CA9 (0.78) | CA9CA12CA1CA7CA13 | |
| SCHEMBL29396102 | 0.87 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| SCHEMBL3924718 | 0.87 | CA9 (0.78) | CA9CA12CA1CA7CA13 | |
| SCHEMBL16015213 | 0.87 | CA9 (0.77) | CA9CA12CA1CA7CA13 | |
| Methoxymethane SCHEMBL2253445 | 0.86 | CA9 (0.97) | CA9CA12CA1CA7CA13 | |
| SCHEMBL14316132 | 0.83 | CA9 (0.71) | CA9CA12CA1CA7CA13 | |
| SCHEMBL14296929 | 0.83 | KDM4E (0.71) | CA9CA12CA1CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302799-A1 | PHARMACEUTICAL COMPOSITION CONTAINING FRAXETIN FOR PREVENTION OR TREATMENT OF ENDOMETRIOSIS | Research & Business Foundation Sungkyunkwan University (KR) | 2025-10-02 | — | — | US | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4479540-A1 | COUMARIN SYNTHESIS AND USES THEREOF | BASF SE (DE) | 2024-12-25 | — | — | EP | claimed |
| US-20240392220-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. | 2024-11-28 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| EP-4408967-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. (US) | 2024-08-07 | — | — | EP | claimed |
| EP-4362756-A1 | NUT BUTTER REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2024-05-08 | — | — | EP | claimed |
| CN-117159536-A | Application of compound Fraxetin in preparation of medicines for preventing and treating pulmonary fibrosis | 江南大学 | 2023-12-05 | — | — | CN | claimed |
| WO-2023156270-A1 | COUMARIN SYNTHESIS AND USES THEREOF | BASF SE (DE) | 2023-08-24 | — | — | WO | claimed |
| WO-2023055801-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. (US) | 2023-04-06 | — | — | WO | claimed |
| US-20040091589-A1 | Prevention of synthetic color fading in beverages using botanically derived color stabilizers | PEPSICO, INC. | 2004-05-13 | — | — | US | claimed |
| JP-2003532634-A | — | — | 2003-11-05 | — | — | JP | claimed |
| US-6576660-B1 | Treating prostate cancer, breast cancer, obesity, skin disorders and baldness | ARCH DEVELOPMENT CORPORATION | 2003-06-10 | — | — | US | claimed |
| US-20020197370-A1 | Deterioration preventive agent for milk-containing foods | TAKASAGO INTERNATIONAL CORPORATION | 2002-12-26 | — | — | US | claimed |
| US-6475544-B1 | Anti-deterioration agent for food flavors, method for preventing deterioration of food flavors, and foods containing anti-deterioration agent for food flavors | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-11-05 | — | — | US | claimed |
| EP-1244435-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES | Proteotech Inc. (US) | 2002-10-02 | — | — | EP | claimed |
| EP-1240833-A2 | Agent for prevention of deterioration of milk-containing foods | Takasago International Corporation (JP) | 2002-09-18 | — | — | EP | claimed |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2001-11-29 | — | — | US | claimed |
| WO-2001049281-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES | PROTEOTECH, INC. (US) | 2001-07-12 | — | — | WO | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302799-A1 | PHARMACEUTICAL COMPOSITION CONTAINING FRAXETIN FOR PREVENTION OR TREATMENT OF ENDOMETRIOSIS | SFXN1, NR5A1, LPXN | CA9 1223/4885CA12 1057/4885CA1 2559/4885 |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | CA9 4753/4885CA12 4845/4885CA1 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.